From first-in-human cardiovascular studies to complex late-phase programs, CR2O partners with cardiology sites and KOLs to deliver trials with scientific depth and operational precision.
Atherosclerosis and lipid management
Anti-thrombotic and anti-platelet
Arrhythmia and electrophysiology
Cardio-renal and cardio-metabolic
Structural heart and interventional
A selection of the cardiology studies we deliver.
An ongoing post-operative outcomes study in 300 patients undergoing coronary artery bypass graft surgery, running across sites in the Netherlands, Germany and the USA.